Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Methicillin-resistant Staphylococcus Aureus Septicemia”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableUnknownNCT01352936
What this trial is testing

Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy

Who this might be right for
Staphylococcus AureusBacteremia
Taipei Medical University WanFang Hospital 190
Not applicableStudy completedNCT01995760
What this trial is testing

The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?

Who this might be right for
Methicillin-resistant Staphylococcus Aureus Septicemia
National Taiwan University Hospital 123
Large-scale testing (Phase 3)Ended earlyNCT01515020
What this trial is testing

Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia

Who this might be right for
Nosocomial InfectionHealthcare-associated Infection
Assistance Publique - Hôpitaux de Paris 10
Post-approval studies (Phase 4)Study completedNCT01701219
What this trial is testing

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus BacteremiaMethicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia
Forest Laboratories 56
Post-approval studies (Phase 4)Looking for participantsNCT06637332
What this trial is testing

Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus Bacteremia+2 more
Todd C. Lee MD MPH FIDSA 300
Not applicableEnded earlyNCT01640886
What this trial is testing

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

Who this might be right for
Bacteremia
MicroPhage, Inc. 764
Large-scale testing (Phase 3)Study completedNCT01898338
What this trial is testing

Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

Who this might be right for
Staph Aureus Methicillin Resistant Bacteremia
Miquel Pujol 167
Large-scale testing (Phase 3)Study completedNCT00427076
What this trial is testing

Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections

Who this might be right for
Staphylococcal InfectionsMeningitisSepsis+1 more
Rabin Medical Center 252
Large-scale testing (Phase 3)Study completedNCT01817075
What this trial is testing

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Who this might be right for
Bacterial InfectionBenign NeoplasmMalignant Neoplasm+4 more
Children's Oncology Group 177
Not applicableLooking for participantsNCT05975671
What this trial is testing

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

Who this might be right for
SepsisSepsis MrsaSepsis Bacteremia+4 more
Children's Hospital of Philadelphia 52,500
Testing effectiveness (Phase 2)Ended earlyNCT01975662
What this trial is testing

Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia

Who this might be right for
Bacteremia Due to Staphylococcus Aureus
Singapore General Hospital 14
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Early research (Phase 1)Study completedNCT02945241
What this trial is testing

Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

Who this might be right for
Methicillin-resistant Staphylococcus AureusSepsisCritical Illness
Mayo Clinic 399
Large-scale testing (Phase 3)Study completedNCT00770341
What this trial is testing

MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

Who this might be right for
Staphylococcal Infection
Merck Sharp & Dohme LLC 122
Not applicableStudy completedNCT01184339
What this trial is testing

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Who this might be right for
Bacteremia
MicroPhage, Inc. 1,165
Not applicableLooking for participantsNCT06958835
What this trial is testing

Linezolid Plus Standard of Care

Who this might be right for
Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
University Hospital, Basel, Switzerland 606
Post-approval studies (Phase 4)Study completedNCT02660346
What this trial is testing

IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB

Who this might be right for
Bacteremia
Sharp HealthCare 40
Post-approval studies (Phase 4)UnknownNCT02443064
What this trial is testing

Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin

Who this might be right for
Blood Stream InfectionsEndocarditisMRSA
Zhejiang University 100
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Not applicableNo Longer AvailableNCT04597242
What this trial is testing

Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia

Who this might be right for
MRSA Bloodstream InfectionMRSA BacteremiaMRSA Right-sided Endocarditis+1 more
ContraFect
Load More Results